Sign in
4

Changes in Ownership

XBiotech Inc. Filed Acc 0001209191-17-041608

Options or other derivatives

  • VP Research and Development acquired 50,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
SHIVASWAMY SUSHMA VP Research and Development 2017-06-19 Option exercise · Stock Option +50,000 $4.24 $212,000 50,000 D: show line 1 in the form
Loading xslF345X03/doc4.xml…